Equities analysts expect Surgery Partners Inc (NASDAQ:SGRY) to post earnings per share of ($0.14) for the current quarter, according to Zacks Investment Research. Four analysts have made estimates for Surgery Partners’ earnings. The highest EPS estimate is ($0.08) and the lowest is ($0.21). Surgery Partners reported earnings per share of ($0.18) in the same quarter last year, which would suggest a positive year-over-year growth rate of 22.2%. The company is expected to announce its next earnings results on Thursday, August 8th.
On average, analysts expect that Surgery Partners will report full-year earnings of ($0.41) per share for the current year, with EPS estimates ranging from ($0.75) to ($0.15). For the next year, analysts forecast that the company will report earnings of $0.24 per share, with EPS estimates ranging from ($0.36) to $0.62. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that follow Surgery Partners.
Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings data on Wednesday, May 8th. The company reported ($0.42) earnings per share for the quarter, missing the consensus estimate of ($0.39) by ($0.03). Surgery Partners had a negative net margin of 11.59% and a negative return on equity of 4.01%. The firm had revenue of $416.80 million during the quarter, compared to analysts’ expectations of $421.41 million. During the same period in the previous year, the business earned ($0.26) earnings per share. The business’s revenue for the quarter was up 1.3% on a year-over-year basis.
In other Surgery Partners news, Director Adam T. Feinstein sold 7,865 shares of the stock in a transaction on Monday, May 20th. The stock was sold at an average price of $9.95, for a total transaction of $78,256.75. Following the sale, the director now owns 8,895 shares in the company, valued at approximately $88,505.25. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.30% of the stock is currently owned by corporate insiders.
Large investors have recently made changes to their positions in the business. Quantamental Technologies LLC acquired a new stake in shares of Surgery Partners during the first quarter worth $50,000. Metropolitan Life Insurance Co. NY boosted its holdings in shares of Surgery Partners by 351.4% during the fourth quarter. Metropolitan Life Insurance Co. NY now owns 6,766 shares of the company’s stock worth $66,000 after purchasing an additional 5,267 shares during the last quarter. Menta Capital LLC acquired a new stake in shares of Surgery Partners during the fourth quarter worth $99,000. Redmile Group LLC acquired a new stake in shares of Surgery Partners during the first quarter worth $179,000. Finally, Principal Financial Group Inc. boosted its holdings in shares of Surgery Partners by 9.5% during the fourth quarter. Principal Financial Group Inc. now owns 19,325 shares of the company’s stock worth $189,000 after purchasing an additional 1,672 shares during the last quarter. Hedge funds and other institutional investors own 96.75% of the company’s stock.
NASDAQ SGRY traded down $0.16 during mid-day trading on Friday, hitting $7.90. The stock had a trading volume of 259,128 shares, compared to its average volume of 359,082. Surgery Partners has a 52-week low of $7.64 and a 52-week high of $18.70. The firm has a market cap of $390.48 million, a P/E ratio of -3.22 and a beta of 2.28. The stock has a 50 day moving average price of $8.81. The company has a current ratio of 1.49, a quick ratio of 1.37 and a debt-to-equity ratio of 2.20.
About Surgery Partners
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Further Reading: Blue-Chip Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.